<< Back to Research archive

Published on: May 22, 2024

Strong growth, again

The trading update for the half year ended 30 April is confident. First-half growth in revenues was over 20% year on year. The Emapsite acquisition has performed well. Cash generation has been impressive, with H1 net debt at c.£6.6m versus £14.7m at the FY23 year-end. The M&A pipeline is very healthy too. This strong performance is in line with management’s expectations, and the group expects to deliver to plan across the remainder of the year.

Related Content